Recent developments which may impact consumer access to, and demand for, pharmaceuticals : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Seventh Congress, first session, June 13, 2001.

Prescription drug price increases [microform] : hearing before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, Ninety-ninth Congress, first session, July 15, 1985.

United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health and the Environment.

January 1986

"Serial no. 99-58."CIS Microfiche Accession Numbers: CIS 86 H361-28Includes bibliographies.Microfich...

Examining issues related to competition in the pharmaceutical marketplace : a review of the FTC report, Generic drug entry prior to patent expiration : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Seventh Congress, second session, October 9, 2002.

United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health.

January 2002

"Serial no. 107-140."Shipping list no.: 2003-0102-P.Distributed to some depository libraries in micr...

Drug user fees : enhancing patient access and drug safety : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Tenth Congress, first session, on examining enhancing patient access and drug safety relating to prescription drug user fees, including S. 484, March 14, 2007.

United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions.

January 2008

Shipping list no.: 2009-0056-P.Distributed to some depository libraries in microfiche.Mode of access...

Continuing concerns over imported pharmaceuticals : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Seventh Congress, first session, June 7, 2001.

United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations.

January 2001

"Serial no. 107-30."Shipping list no.: 2001-0304-P.Distributed to some depository libraries in micro...

Generic pharmaceuticals : marketplace access and consumer issues : hearing before the Committee on Commerce, Science, and Transportation, United States Senate, One Hundred Seventh Congress, second session, April 23, 2002.

United States. Congress. Senate. Committee on Commerce, Science, and Transportation.

January 2004

Shipping list no.: 2005-0001-P.Distributed to some depository libraries in microfiche."Printed for t...

Prescription drugs : modernizing Medicare for the 21st century : hearing before the Subcommittee on Health and Environment of the Committee on Commerce, House of Representatives, One Hundred Sixth Congress, second session, June 14, 2000.

United States. Congress. House. Committee on Commerce. Subcommittee on Health and the Environment.

January 2000

"Serial no. 106-110."Shipping list no.: 2000-0359-P.Distributed to some depository libraries in micr...

The changing face of healthcare in the electronic age : hearing before the Subcommittee on Technology of the Committee on Science, House of Representatives, One Hundred Sixth Congress, second session, March 30, 2000.

United States. Congress. House. Committee on Science. Subcommittee on Technology.

January 2000

"Serial no. 106-73."Shipping list no.: 2000-0312-P.Distributed to some depository libraries in micro...

Emerging health care issues : follow-on biologic drug competition : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Eleventh Congress, first session, June 11, 2009.

United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health.

January 2012

"Serial no. 111-46."Shipping list no.: 2012-0411-P.Includes bibliographical references.Mode of acces...

Technology and prescription drug safety : hearing before the Special Committee on Aging, United States Senate, One Hundred Seventh Congress, first session, Washington, DC, May 3, 2001.

United States. Congress. Senate. Special Committee on Aging.

January 2001

"Serial no. 107-4."Shipping list no.: 2001-0305-P.Distributed to some depository libraries in microf...

Modernizing Medicare : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Seventh Congress, first session, July 26, 2001.

United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health.

January 2001

"Serial no. 107-53."Shipping list no.: 2002-0042-P.Distributed to some depository libraries in micro...

Drug safety and pricing : hearing before the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Sixth Congress, second session ... June 13, 2000.

United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions.

January 2000

Shipping list no.: 2001-0035-P.Distributed to some depository libraries in microfiche.Includes bibli...

The economic aspects of the pharmaceutical industry in the United States : hearing before the Subcommittee on Human Rights and Wellness of the Committee on Government Reform, House of Representatives, One Hundred Eighth Congress, first session, June 25, 2003.

United States. Congress. House. Committee on Government Reform. Subcommittee on Human Rights and Wellness.

January 2003

"Serial no. 108-63."Distributed to some depository libraries in microfiche.Shipping list no.: 2004-0...

The next generation of health information tools for consumers : hearing before the Joint Economic Committee, Congress of the United States, One Hundred Ninth Congress, second session, May 10, 2006.

United States. Congress. Joint Economic Committee.

January 2006

Distributed to some depository libraries in microfiche.Shipping list no.: 2007-0181-P."Printed for t...

Prescription drug costs : what drives increases? : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, 106th Congress, 2nd session ... July 18, 2000.

United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions.

January 2000

Shipping list no.: 2001-0024-P.Distributed to some depository libraries in microfiche."Printed for t...

Examining the Senate and House versions of the "Greater Access to Affordable Pharmaceuticals Act" : hearing before the Committee on the Judiciary, United States Senate, One Hundred Eighth Congress, first session, August 1, 2003.

United States. Congress. Senate. Committee on the Judiciary.

January 2004

"Serial no. J-108-34."Shipping list no.: 2004-0161-P.Distributed to some depository libraries in mic...

Prescription drug price increases [microform] : hearing before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, Ninety-ninth Congress, first session, July 15, 1985.

United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health and the Environment.

January 1986

"Serial no. 99-58."CIS Microfiche Accession Numbers: CIS 86 H361-28Includes bibliographies.Microfich...

Examining issues related to competition in the pharmaceutical marketplace : a review of the FTC report, Generic drug entry prior to patent expiration : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Seventh Congress, second session, October 9, 2002.

United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health.

January 2002

"Serial no. 107-140."Shipping list no.: 2003-0102-P.Distributed to some depository libraries in micr...

Drug user fees : enhancing patient access and drug safety : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Tenth Congress, first session, on examining enhancing patient access and drug safety relating to prescription drug user fees, including S. 484, March 14, 2007.

United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions.

January 2008

Shipping list no.: 2009-0056-P.Distributed to some depository libraries in microfiche.Mode of access...

Continuing concerns over imported pharmaceuticals : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Seventh Congress, first session, June 7, 2001.

United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations.

January 2001

"Serial no. 107-30."Shipping list no.: 2001-0304-P.Distributed to some depository libraries in micro...

Generic pharmaceuticals : marketplace access and consumer issues : hearing before the Committee on Commerce, Science, and Transportation, United States Senate, One Hundred Seventh Congress, second session, April 23, 2002.

United States. Congress. Senate. Committee on Commerce, Science, and Transportation.

January 2004

Shipping list no.: 2005-0001-P.Distributed to some depository libraries in microfiche."Printed for t...

Prescription drugs : modernizing Medicare for the 21st century : hearing before the Subcommittee on Health and Environment of the Committee on Commerce, House of Representatives, One Hundred Sixth Congress, second session, June 14, 2000.

United States. Congress. House. Committee on Commerce. Subcommittee on Health and the Environment.

January 2000

"Serial no. 106-110."Shipping list no.: 2000-0359-P.Distributed to some depository libraries in micr...

The changing face of healthcare in the electronic age : hearing before the Subcommittee on Technology of the Committee on Science, House of Representatives, One Hundred Sixth Congress, second session, March 30, 2000.

United States. Congress. House. Committee on Science. Subcommittee on Technology.

January 2000

"Serial no. 106-73."Shipping list no.: 2000-0312-P.Distributed to some depository libraries in micro...

Emerging health care issues : follow-on biologic drug competition : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Eleventh Congress, first session, June 11, 2009.

United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health.

January 2012

"Serial no. 111-46."Shipping list no.: 2012-0411-P.Includes bibliographical references.Mode of acces...

Technology and prescription drug safety : hearing before the Special Committee on Aging, United States Senate, One Hundred Seventh Congress, first session, Washington, DC, May 3, 2001.

United States. Congress. Senate. Special Committee on Aging.

January 2001

"Serial no. 107-4."Shipping list no.: 2001-0305-P.Distributed to some depository libraries in microf...

Modernizing Medicare : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Seventh Congress, first session, July 26, 2001.

United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health.

January 2001

"Serial no. 107-53."Shipping list no.: 2002-0042-P.Distributed to some depository libraries in micro...

Drug safety and pricing : hearing before the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Sixth Congress, second session ... June 13, 2000.

United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions.

January 2000

Shipping list no.: 2001-0035-P.Distributed to some depository libraries in microfiche.Includes bibli...

The economic aspects of the pharmaceutical industry in the United States : hearing before the Subcommittee on Human Rights and Wellness of the Committee on Government Reform, House of Representatives, One Hundred Eighth Congress, first session, June 25, 2003.

United States. Congress. House. Committee on Government Reform. Subcommittee on Human Rights and Wellness.

January 2003

"Serial no. 108-63."Distributed to some depository libraries in microfiche.Shipping list no.: 2004-0...

The next generation of health information tools for consumers : hearing before the Joint Economic Committee, Congress of the United States, One Hundred Ninth Congress, second session, May 10, 2006.

United States. Congress. Joint Economic Committee.

January 2006

Distributed to some depository libraries in microfiche.Shipping list no.: 2007-0181-P."Printed for t...

Prescription drug costs : what drives increases? : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, 106th Congress, 2nd session ... July 18, 2000.

United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions.

January 2000

Shipping list no.: 2001-0024-P.Distributed to some depository libraries in microfiche."Printed for t...

Examining the Senate and House versions of the "Greater Access to Affordable Pharmaceuticals Act" : hearing before the Committee on the Judiciary, United States Senate, One Hundred Eighth Congress, first session, August 1, 2003.

United States. Congress. Senate. Committee on the Judiciary.

January 2004

"Serial no. J-108-34."Shipping list no.: 2004-0161-P.Distributed to some depository libraries in mic...

Prescription drug price increases [microform] : hearing before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, Ninety-ninth Congress, first session, July 15, 1985.

United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health and the Environment.

January 1986

"Serial no. 99-58."CIS Microfiche Accession Numbers: CIS 86 H361-28Includes bibliographies.Microfich...

Examining issues related to competition in the pharmaceutical marketplace : a review of the FTC report, Generic drug entry prior to patent expiration : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Seventh Congress, second session, October 9, 2002.

United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health.

January 2002

"Serial no. 107-140."Shipping list no.: 2003-0102-P.Distributed to some depository libraries in micr...

Drug user fees : enhancing patient access and drug safety : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Tenth Congress, first session, on examining enhancing patient access and drug safety relating to prescription drug user fees, including S. 484, March 14, 2007.

United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions.

January 2008

Shipping list no.: 2009-0056-P.Distributed to some depository libraries in microfiche.Mode of access...

Recent developments which may impact consumer access to, and demand for, pharmaceuticals : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Seventh Congress, first session, June 13, 2001.

Abstract

Extracted data

Recent developments which may impact consumer access to, and demand for, pharmaceuticals : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Seventh Congress, first session, June 13, 2001.

Abstract

Extracted data

Related items

Related items